Across TCGA pan-cancer cohorts, RNA5SP79 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNA5SP79’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RNA5SP79 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP79 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LIHC, BRCA, and CHOL are the cancer types where RNA5SP79 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP79 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.418	<.001	6	view →
BRCA	Female	II,III,IV	+0.182	.004	4	view →
CHOL	All	All	+0.742	.029	1	view →
KICH	Female	All	+0.203	.033	1	view →
THCA	All	All	−0.039	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNA5SP79 RNA expression & survival · all RNA5SP79 data types